Table 3.

Baseline characteristics of all patients with newly diagnosed hypertension

VariablePatients with available data, n/n screened/non-screenedScreenedNon-screenedP-valuea
Demographics
  Male, n (%)343/3387177 (51.6)1586 (46.8)0.146
  Age, years343/338753.4 (11.1)58.5 (13.4)<0.001
  BMI, kg/m2, n (%)222/13770.133
    ≤2548 (21.6)383 (27.8)
    >25–≤30102 (45.9)576 (41.8)
    >3072 (32.4)418 (30.4)
  Smoking status, n (%)172/5970.841
    Current38 (22.1)135 (22.6)
    Former56 (32.6)218 (36.5)
    Never78 (45.3)244 (40.9)
Blood pressure, mean (SD)
  Systolic BP, mmHg341/2880163.6 (13.3)156.3 (11.8)<0.001
  Diastolic BP, mmHg338/288096.3 (9.9)89.8 (9.5)<0.001
  ABPM, mmHg49/229154.7 (15.6)147.0 (12.9)0.001
  ABPMday, mmHg43/204159.4 (15.4)152.1 (12.8)0.003
  Home BP, mmHg2/12160.0 (0)144.0 (5.2)
  Heart rate, beats/minute199/165975.0 (12.6)74.5 (12.1)0.742
Biochemical parameters
  Serum potassium, mmol/l, mean (SD)341/17854.42 (0.34)4.37 (0.37)0.044
  Serum sodium, mmol/l, mean (SD)341/1685141.7 (2.0)141.9 (2.1)0.084
  Serum creatinine, µmol/l, mean (SD)341/199678.8 (14.6)78.9 (15.2)0.871
  Aldosterone, pmol/l, mean (SD)343/0369.0 (223.8)
  Renin, pmol/l, median (IQR)343/00.77 (0.58 to 1.31)
  ARR, pmol/mU, mean (SD)343/031.8 (26.6)
  Serum glucose, mmol/l, mean (SD)310/17865.43 (1.01)5.45 (0.83)0.546
Cardiovascular morbidity, n (%)
  OSAS343/33875 (1.5)41 (1.2)0.714
  Atrial fibrillation343/33872 (0.6)52 (1.5)0.166
  Stroke343/33872 (0.6)156 (4.6)0.003
  Myocardial infarction343/33872 (0.6)32 (0.9)0.597
  • a P-value calculated by univariate multilevel analyses. ABPM = systolic ambulatory blood pressure monitoring. ABPMday = daytime systolic ambulatory blood pressure monitoring. ARR = aldosterone-to-renin ratio. BMI = body mass index. Home BP = home systolic blood pressure. IQR = interquartile range. OSAS = obstructive sleep apnoea syndrome. PA = primary aldosteronism. SD = standard deviation.